Advances in Extra-Corporeal Perfusion Therapies 2019
DOI: 10.5772/intechopen.76925
View full text |Buy / Rent full text
|
Sign up to set email alerts
|

Abstract: Cardiogenic shock (CS) still remains a leading cause of hospital death. The adoption of percutaneous ventricular assist devices (pVADs) as treatment of CS is an option which continues to rise. Several types of pVADs have been developed by time to provide full cardiac support with few related complications and easy implantation settings. pVADs are used to support the failing heart as a bridge to recovery, decision, durable device or heart transplantation. None of these devices adopted in the clinical practice i… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles